Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.

Stone RL, Baggerly KA, Armaiz-Pena GN, Kang Y, Sanguino AM, Thanapprapasr D, Dalton HJ, Bottsford-Miller J, Zand B, Akbani R, Diao L, Nick AM, DeGeest K, Lopez-Berestein G, Coleman RL, Lutgendorf S, Sood AK. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer. Cancer Biol Ther. 2014 Jul; 15(7):919-29.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Animals
Cell Movement
Cell Proliferation
Endothelial Cells
Female
Focal Adhesion Protein-Tyrosine Kinases
Gene Dosage
Humans
Indoles
Mice, Nude
Neoplasm Metastasis
Neoplasms, Glandular and Epithelial
Neovascularization, Pathologic
Ovarian Neoplasms
Phosphorylation
Protein Kinase Inhibitors
Sulfonamides
Tyrosine

authors with profiles

Guillermo N Armaiz Pena

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support